Cytokine-induced changes in chromatin structure and in vivo footprints in the inducible NOS promoter

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Mellott, Jane K ^a   Nick, Harry S ^b   Waters, Michael F ^a   Billiar, Timothy R ^c   Geller, David A ^c   Chesrown, Sarah E ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Deoxyribonuclease I hypersensitive sites; Inflammatory cytokines; Liver epithelial cells; Lung epithelial cells; Nitric oxide synthase

Indexed keywords

CYTOKINE; DEOXYRIBONUCLEASE I; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA FLANKING REGION; DNA FOOTPRINTING; ENZYME ACTIVE SITE; GENE MAPPING; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; REGULATORY MECHANISM; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0035000016     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l390     Document Type: Article

References (42)

1. Barnes PJ. Nitric oxide and asthma. Res Immunol 146: 698-702, 1995.
2. Basuyaux JP, Ferreira E, Stehelin D, and Buttice GJ. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct domains in a DNA-dependent and -independent manner. J Biol Chem 272: 26188-26195, 1997.
3. Blackford JA Jr, Antonini JM, Castranova V, and Dey RD. Intratracheal instillation of silica up-regulates inducible nitric oxide synthase gene expression and increases nitric oxide production in alveolar macrophages and neutrophils. Am J Respir Cell Mol Biol 11: 426-431, 1994.
4. Botelho FM, Edwards DR, and Richards CD. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter. J Biol Chem 273: 5211-5218, 1998.
5. Charles IG, Palmer RM, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, and Moncada S. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90: 11419-11423, 1993.
6. Del Pozo V, de Arruda-Chaves E, de Andres B, Cardaba B, Lopez-Farre A, Gallardo S, Cortegano I, Vidarte L, Jurado A, Sastre J, Palomino P, and Lahoz CJ. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. Immunology 158: 859-864, 1997.
7. De Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM Jr, Billiar TR, and Geller DA. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93: 1054-1059, 1996.
8. Evans CH. Nitric oxide: what role does it play in inflammation and tissue destruction? Agents Actions Suppl 47: 107-116, 1995.
9. Fritton HP, Igo-Kemenes T, Nowock J, Strech-Jurk U, Theisen M, and Sippel AE. Alternative sets of DNase I-hypersensitive sites characterize the various functional states of the chicken lysozyme gene. Nature 311: 163-165, 1984.
10. Fuchs B, Wagner T, Rossel N, Antoine M, Beug H, and Niessing J. Structure and erythroid cell-restricted expression of a chicken cDNA encoding a novel zinc finger protein of the Cys + His class. Gene 195: 277-284, 1997.
11. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, and Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491-3495, 1993.
12. Gross DS and Garrard WT. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 57: 159-197, 1988.
13. Guo FH, Comhair SAA, Zheng S, Dweik RA, Eissa NT, Thomassen MJ, Calhoun W, and Erzurum SC. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 164: 5970-5980, 2000.
14. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, and Polak JM. Induction of nitric oxide synthase in asthma. Lancet 342: 1510-1513, 1993.
15. Hangai M, Yoshimura N, Hiroi K, Mandai M, and Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res 63: 501-509, 1996.
16. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, and Tweardy DJ. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187: 917-928, 1998.
17. Hornstra IK and Yang TP. In vivo footprinting and genomic sequencing by ligation-mediated PCR. Anal Biochem 213: 179-193, 1993.
18. Koda W, Harada K, Tsuneyama K, Kono N, Sasaki M, Matsui O, and Nakanuma Y. Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along the intrahepatic biliary tree. Lab Invest 80: 1007-1017, 2000.
19. Kroncke KD, Fehsel K, and Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156, 1998.
20. Kuo S, Chesrown SE, Mellott JK, Rogers RJ, Hsu IL, and Nick H. In vivo architecture of the manganese superoxide dismutase promoter. J Biol Chem 274: 3345-3354, 1999.
21. Laubach VE, Zhang CX, Russell SW, Murphy WJ, and Sherman PA. Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes. Biochim Biophys Acta 1351: 287-295, 1997.
22. Li G, Chandler SP, Wolffe AP, and Hall TC. Architectural specificity in chromatin structure at the TATA box in vivo: nucleosome displacement upon beta-phaseolin gene activation. Proc Natl Acad Sci USA 95: 4772-4777, 1998.
23. Lieber M, Smith B, Szakal A, Nelson-Rees W, and Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17: 62-70, 1976.
24. Linn SC, Morelli PJ, Edry I, Cottongim SE, Szabo C, and Salzman AL. Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol Gastrointest Liver Physiol 272: G1499-G1508, 1997.
25. Majano PL, Garcia-Monzon C, Lopez-Cabrera M, Lara-Pezzi E, Fernandez-Ruiz E, Garcia-Iglesiase C, Borque MJ, and Moreno-Otero R. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest 101: 1343-1352, 1998.
26. Marks-Konczalik J, Chu SC, and Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 273: 22201-22208, 1998.
27. Morris SM Jr and Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol Endocrinol Metab 266: E829-E839, 1994.
28. Nunokawa Y, Oikawa S, and Tanaka S. Expression of human inducible nitric oxide synthase is regulated by both promoter and 3′-regions. Biochem Biophys Res Commun 233: 523-526, 1997.
29. Nussler AK and Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54: 171-178, 1993.
30. Nussler AK, Vergani G, Gollin SM, Dorko K, Gansauge S, Morris SM Jr, Demetris AJ, Nomoto M, Beger HG, and Strom SC. Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver. In Vitro Cell Dev Biol Anim 35: 190-197, 1999.
31. Nye JA, Petersen JM, Gunther CV, Jonsen MD, and Graves BJ. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 6: 975-990, 1992.
32. Pfeifer GP and Riggs AD. Chromatin differences between active and inactive X chromosomes revealed by genomic foot-printing of permeabilized cells using DNase I and ligation-mediated PCR. Genes Dev 5: 1102-1113, 1991.
33. Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Geller DA, and Polak JM. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 203: 209-218, 1994.
34. Salzman AL. Nitric oxide in the gut. New Horiz 3: 352-364, 1995.
35. Spitsin SV, Koprowski H, and Michaels FH. Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. Mol Med 2: 226-235, 1996.
36. Taylor BS, Alarcon LH, and Billiar TR. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc) 63: 766-781, 1998.
37. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr, Billiar TR, and Geller DA. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273: 15148-15156, 1998.
38. Thomas RS, Tymms MJ, McKinlay LH, Shannon MF, Seth A, and Kola I. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 14: 2845-2855, 1997.
39. Visner GA, Dougall WC, Wilson JM, Burr IA, and Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J Biol Chem 265: 2856-2864, 1990.
40. Worrall NK, Boasquevisque CH, Misko TP, Sullivan PM, Ferguson TB Jr, and Patterson GA. Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant 16: 334-339, 1997.
41. Yun HY, Dawson VL, and Dawson TM. Nitric oxide in health and disease of the nervous system. Mol Psychiatry 2: 300-310, 1997.
42. Zweidler-Mckay PA, Grimes HL, Flubacher MM, and Tsichlis PN. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 16: 4024-4034, 1996.